MARATTO

article · Journal of Inflammation Research

Exploring the Association of Interleukin 13 Polymorphism (rs20541) and Serum Lipocalin 2 with Risk and Disability in Multiple Sclerosis

2026Open accessZagazig University

Abstract

The research makes a substantial contribution to the literature on the perceived significance of value of <i>IL-13</i> polymorphism to the risk of MS, while LCN2 is linked to both risk and disability of MS.

Research topics

  • Psoriasis: Treatment and Pathogenesis
  • Acute Kidney Injury Research
  • Immune Response and Inflammation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2147/jir.s578371

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.